A Study of LY2951742 in Participants With Migraine

NCT01625988 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Headache

Interventions

DRUG: LY2951742
DRUG: Placebo

Sponsor

Eli Lilly and Company